Home

The Latest Stories

Surgery halts seizures in many epileptics: study

LONDON (Reuters) - Almost half of epilepsy patients who have surgery find that it stops their seizures completely for at least 10 years, scientists said on Friday, suggesting an effective alternative to costly and difficult drug treatment.

In the first long-term study of post-surgery epilepsy patients, British researchers found that 82 percent of them were seizure-free after one year, 52 percent ...

Nearly too weak to cry, Masteha Jama Mohamed's three-month-old daughter is barely the length of her forearm, as the severely malnourished baby struggles for survival in famine-hit Somalia.

Mohamed is herself just a teenager: the 16-year-old mother says her baby has been sick ever since she was two weeks old, and now at 2.5 kilogrammes, is still only ...

Lundbeck won't pull drug used in U.S. executions

LONDON (Reuters) - Danish drugmaker Lundbeck will continue to sell a drug used in U.S. executions since pulling it off the market would be bad for some patients with severe epilepsy, its CEO said on Wednesday.

The company has found itself at the center of a storm because Nembutal, also known generically as pentobarbital, is increasingly used in lethal injections ...

Biden and Axelrod make fight against epilepsy personal

CHICAGO (Reuters) - Vice President Joseph Biden on Tuesday tapped into his own medical history to lead a big fundraiser for researching a cure for epilepsy, which he called "a terrible lightning storm in the brain."

Biden and former White House colleague David Axelrod, whose daughter Lauren lives with epilepsy, headlined the event that raised about $800,000 for research. Chicago ...

Missed or late medicine doses common in epileptic kids

CHICAGO (Reuters) - Nearly three of five children with newly diagnosed epilepsy do not take their antiepileptic medications as prescribed over the first six months of therapy, U.S. researchers said on Tuesday.

Children from the poorest families in the study were least likely to take their medications as directed, the researchers said.

Only 42 percent of children who were newly ...

Epilepsy killed celebrity polar bear Knut: report

FRANKFURT (Reuters) - Knut, the celebrity orphan polar bear who drew thousands of visitors to Berlin zoo, died after an epileptic fit, according to neurologists quoted by Focus magazine.

A CAT scan had revealed abormalities in the brain of the bear, who may have inherited epilepsy from his father Lars, also a sufferer.

Four year-old Knut, who won global fame as ...

Epilepsy drugs linked to more broken bones

NEW YORK (Reuters Health) - Older adults on certain epilepsy drugs have an increased risk of breaking their wrist, hip or spine, according to a new Canadian study.

The drugs have been suspected of weakening bones for years, researchers say, but whether individual medications are different hadn't been clear.

The Canadian team found patients on all but one of 15 ...

Parents prompt epilepsy study, gain 10,000 followers less than a year after son's tragic death

Epilepsy takes as many as 50,000 lives each year — grim statistics Mike and Mariann Stanton hadn't heard of until their 4-year-old son, Danny, became one of them.

Somehow, that horrible tragedy a year ago transformed a blissfully ordinary Chicago family into ...

Pharmaceutical company Elan agrees to pay more than $203 million to settle case with govt

Irish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary have agreed to pay more than $203 million for alleged illegal promotion of the epilepsy drug Zonegran, the Justice Department said Wednesday.

The department said Japanese drug marketer Eisai Inc., which bought the drug ...

FDA declines to OK Glaxo epilepsy drug for now

NEW YORK (Reuters) - The U.S. Food and Drug Administration declined to approve an experimental epilepsy drug from GlaxoSmithKline and Valeant Pharmaceuticals International, the companies said on Wednesday, marking another delay for the anti-seizure medicine.

The drugmakers received a so-called complete response letter from the agency for the drug ezogabine, meaning the FDA will not approve the medicine until certain ...

Previous